Alembic Pharmaceuticals Limited (APLLTD.NS)
Makes generic medicines and active ingredients for hospitals and pharmacies globally.
811.95-0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-15.3%
The outlook
Alembic Pharmaceuticals is trading above both its 50- and 200-day moving averages, sitting midway in its 52-week range. Analysts lean toward a buy, with an average price target about 13% above the current level. The stock carries a trailing P/E of 23.7 and shows a leaning bullish sentiment overall.
What’s behind the score
Analyst consensusBuy — 2.2 avg of 10 analysts
Price trendAbove its 50- & 200-day averages
52-week range45% of the way from its 52-week low to high
Price targetAvg target +13% vs current price
Analyst price target
~12-month · 10 analysts918.20average target+13.1% vs now
Now 811.95
Low 750.00High 1,132.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$159.60B
52-wk high
1,026.20
52-wk low
635.80
50-day avg
781.60
200-day avg
794.73
Trailing P/E
23.7